NARSAD
Welcome, guest
[login or register]
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Laurence Tecott, M.D., Ph.D. (Independent Investigator 2001) of University of California, San Francisco, notes that while serotonin, dopamine and norepinephrine are commonly discussed as separate entities with independent functions, there is growing appreciation of the interactions of these neurotransmitter systems. It is now recognized that serotonin suppresses activity in both dopamine and norepinephrine systems. A defect in these actions of serotonin has been proposed as a possible causative factor in bipolar disorder . Because evidence implicates the serotonin 5-HT2C receptor in this dampening effect, diminished function of this receptor could lead to hyperactivity of the dopamine and norepinephrine systems. Interestingly, a line of mice with a mutation of the 5-HT2C receptor gene exhibits behavioral features reminiscent of mania, including reduced behavioral inhibition, reduced sleep and hyperactivity. Dr. Tecott aims to determine the extent to which the behavioral abnormalities of these mice assemble features of mania. His team will determine whether behavioral abnormalities may be reversed by administration of lithium chloride and valproate. They will test the hypothesis that both dopamine and norepinephrine systems are hyperactive in these animals by measuring the brain levels of dopamine and norepinephrine. This work will shed light on the potential importance of serotonin/dopamine and serotonin/ norepinephrine interactions to behaviors relevant to psychiatric disease and to the effects of drugs that influence serotonin function.

Program Area: MULTIPLE FOCUS AREAS\Schizophrenia/Mood Disorders

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Independent Investigator application deadline: March 5, 2008

2008 Young Investigator, 2008 Distinguished Investigator and 2008 Staglin Grantees Announced: March, 2008

2008 Distinguished Investigator Earliest Start Date: May 1, 2008

2009 Distinguished Investigator Award application deadline: May 15, 2008

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award application deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Award Earliest Start Date: September 15, 2008

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009





NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us